Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    NFRP Outreach and Invitation for Response

    Forecasted

    The US Army seeks feedback on a potential research agreement (rOTA) for clinical trials of therapies for neurofibromatosis (NF1, NF2, schwannomatosis), requiring cost-sharing and industry partnership.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)

    This grant funds projects to develop, improve, or make accessible research models, tools, and resources for studying human health and diseases, benefiting multiple NIH Institutes or Centers.

    HHS-NIH11Due Sep 28, 2028$833,333

    SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Not Allowed)

    NIH will soon offer funding for small businesses with recent SBIR/STTR Phase II/IIB awards to support technical assistance and late-stage R&D for commercialization, excluding clinical trials.

    HHS-NIH11Due Apr 5, 2029

    Translational Neural Devices (R61/R33 - Clinical Trial Optional)

    Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.

    HHS-NIH11Due Jan 28, 2027

    BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Basic Experimental Studies with Humans Required)

    This grant funds exploratory, multidisciplinary research using invasive neural recording and stimulation in humans to investigate how brain activity produces sensations, thoughts, emotions, and behaviors.

    HHS-NIH11Due Feb 11, 2027$700,000

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.

    HHS-NIH11Forecasted Jul 31, 2027Forecasted